Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female|Neoplasm, Breast|Breast Cancer Metastatic
Interventions: DRUG: Eribulin Injection [Halaven]|DRUG: Paclitaxel injection
Sponsor: Institut fuer Frauengesundheit
Collaborators: Eisai GmbH